Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism,
represents a major cause of morbidity and mortality in patients with cancer. Arterial …

Cancer-associated venous thrombosis is a common condition, although the reported
incidence varies widely between studies depending on patient population, start and duration …

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Associated
Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of …

The association of severe coronavirus disease 2019 (COVID-19) with an increased risk of
venous thromboembolism (VTE) has resulted in specific guidelines for its prevention and …

Background This guideline addressed VTE prevention in hospitalized medical patients,
outpatients with cancer, the chronically immobilized, long-distance travelers, and those with …

Pulmonary embolism is the third most common cause of death from cardiovascular disease
after heart attack and stroke. Sequelae occurring after venous thromboembolism include …

Venous thromboembolism (VTE), defined as deep vein thrombosis, pulmonary embolism, or
both, affects an estimated 300,000–600,000 individuals in the US each year, causing …

Background The clinically appropriate duration of thromboprophylaxis in hospitalized
patients with acute medical illnesses is unknown. In this multicenter, randomized, double …

Background Acutely ill hospitalized medical patients are at risk for VTE. We assessed the
incidence of VTE in the observational International Medical Prevention Registry on Venous …

Background The clinical epidemiology of venous thromboembolism has changed recently
because of advances in identification, prophylaxis, and treatment. We sought to describe …